Director Daniel A. Gajewski was mentioned in the article “Three Reasons Why the SurgiSil Design Patent Case is Important,” published by Managing IP. From the article:

“The second important implication of this judgment is that it might make it easier to obtain design patents – because the USPTO won’t be able to cite as much prior art against applicants.

Daniel Gajewski, director at Sterne Kessler in Washington DC, says this ruling may also make it harder to invalidate design patents once the protections are granted.”